Replies to post #160625 on Biotech Values

[jq1234]

TEVA submitted sNDA in March for thrice-weekly 40mg dose Copaxone. So just to change label.

[genisi]

2Q13 US Copaxone sales reported by Teva were $817M (still stable despite of Tecfidera).